Kristen R. Friedrichs

ASVCP reference interval guidelines: determination of de novo reference intervals in veterinary species and other related topics

Reference intervals (RI) are an integral component of laboratory diagnostic testing and clinical decision-making and represent estimated distributions of reference values (RV) from healthy populations of comparable individuals. Because decisions to pursue diagnoses or initiate treatment are often based on values falling outside RI, the collection and analysis of RV should be approached with diligence. This report is a condensation of the ASVCP 2011 consensus guidelines for determination of de novo RI in veterinary species, which mirror the 2008 Clinical Laboratory and Standards Institute (CLSI) recommendations, but with language and examples specific to veterinary species. Newer topics include robust methods for calculating RI from small sample sizes and procedures for outlier detection adapted to data quality. Because collecting sufficient reference samples is challenging, this document also provides recommendations for determining multicenter RI and for transference and validation of RI from other sources (eg, manufacturers). Advice for use and interpretation of subject-based RI is included, as these RI are an alternative to population-based RI when sample size or inter-individual variation is high. Finally, generation of decision limits, which distinguish between populations according to a predefined query (eg, diseased or non-diseased), is described. Adoption of these guidelines by the entire veterinary community will improve communication and dissemination of expected clinical laboratory values in a variety of animal species and will provide a template for publications on RI. This and other reports from the Quality Assurance and Laboratory Standards (QALS) committee are intended to promote quality laboratory practices in laboratories serving both clinical and research veterinarians.

Reference values: a review

Reference values are used to describe the dispersion of variables in healthy individuals. They are usually reported as population-based reference intervals (RIs) comprising 95% of the healthy population. International recommendations state the preferred method as a priori nonparametric determination from at least 120 reference individuals, but acceptable alternative methods include transference or validation from previously established RIs. The most critical steps in the determination of reference values are the selection of reference individuals based on extensively documented inclusion and exclusion criteria and the use of quality-controlled analytical procedures. When only small numbers of values are available, RIs can be estimated by new methods, but reference limits thus obtained may be highly imprecise. These recommendations are a challenge in veterinary clinical pathology, especially when only small numbers of reference individuals are available.

ASVCP quality assurance guidelines: control of general analytical factors in veterinary laboratories.

Owing to lack of governmental regulation of veterinary laboratory performance, veterinarians ideally should demonstrate a commitment to self-monitoring and regulation of laboratory performance from within the profession. In response to member concerns about quality management in veterinary laboratories, the American Society for Veterinary Clinical Pathology (ASVCP) formed a Quality Assurance and Laboratory Standards (QAS) committee in 1996. This committee recently published updated and peer-reviewed Quality Assurance Guidelines on the ASVCP website. The Quality Assurance Guidelines are intended for use by veterinary diagnostic laboratories and veterinary research laboratories that are not covered by the US Food and Drug Administration Good Laboratory Practice standards (Code of Federal Regulations Title 21, Chapter 58). The guidelines have been divided into 3 reports on 1) general analytic factors for veterinary laboratory performance and comparisons, 2) hematology and hemostasis, and 3) clinical chemistry, endocrine assessment, and urinalysis. This report documents recommendations for control of general analytical factors within veterinary clinical laboratories and is based on section 2.1 (Analytical Factors Important In Veterinary Clinical Pathology, General) of the newly revised ASVCP QAS Guidelines. These guidelines are not intended to be all-inclusive; rather, they provide minimum guidelines for quality assurance and quality control for veterinary laboratory testing. It is hoped that these guidelines will provide a basis for laboratories to assess their current practices, determine areas for improvement, and guide continuing professional development and education efforts.

Histiocytic sarcoma of macrophage origin in a cat: case report with a literature review of feline histiocytic malignancies and comparison with canine hemophagocytic histiocytic sarcoma

Mild nonregenerative anemia was detected in a 9-year-old neutered male domestic shorthair cat during a routine examination. Bone marrow core biopsy revealed erythroid hyperplasia; however, a specific cause was not identified. Over the next 8 months the anemia progressed, eventually becoming mildly regenerative, and moderate thrombocytopenia developed. On ultrasonographic examination, marked splenomegaly, mild hepatomegaly, and abdominal lymphadenopathy were found. Cytologic evaluation of splenic aspirates revealed increased numbers of mildly to moderately pleomorphic histiocytes that frequently had phagocytosed RBCs, leukocytes, and occasionally platelets. Histopathologic examination of the spleen and liver revealed effacement of splenic architecture by a histiocytic sarcoma (HS), and neoplastic histiocytes in hepatic sinusoids. A second bone marrow aspirate revealed neoplastic infiltration by similar cells. The histiocytes in all tissues were mildly to moderately pleomorphic and markedly erythrophagocytic. The immunophenotype of histiocytes in the spleen was CD1c(-)/CD11b(+)/CD18(+)/MHC-II(+), supporting a macrophage cell lineage. The clinical, pathologic, and immunophenotypic findings in this cat were similar to those in hemophagocytic HSs in dogs. To our knowledge, this is the first report of a HS of purported macrophage phenotype in a cat.

ASVCP quality assurance guidelines: control of preanalytical and analytical factors for hematology for mammalian and nonmammalian species, hemostasis, and crossmatching in veterinary laboratories.

In December 2009, the American Society for Veterinary Clinical Pathology (ASVCP) Quality Assurance and Laboratory Standards committee published the updated and peer-reviewed ASVCP Quality Assurance Guidelines on the Societys website. These guidelines are intended for use by veterinary diagnostic laboratories and veterinary research laboratories that are not covered by the US Food and Drug Administration Good Laboratory Practice standards (Code of Federal Regulations Title 21, Chapter 58). The guidelines have been divided into 3 reports: (1) general analytical factors for veterinary laboratory performance and comparisons; (2) hematology, hemostasis, and crossmatching; and (3) clinical chemistry, cytology, and urinalysis. This particular report is one of 3 reports and provides recommendations for control of preanalytical and analytical factors related to hematology for mammalian and nonmammalian species, hemostasis testing, and crossmatching and is adapted from sections 1.1 and 2.3 (mammalian hematology), 1.2 and 2.4 (nonmammalian hematology), 1.5 and 2.7 (hemostasis testing), and 1.6 and 2.8 (crossmatching) of the complete guidelines. These guidelines are not intended to be all-inclusive; rather, they provide minimal guidelines for quality assurance and quality control for veterinary laboratory testing and a basis for laboratories to assess their current practices, determine areas for improvement, and guide continuing professional development and education efforts.

Laboratory evaluation and interpretation of synovial fluid

Canine and feline joint disease can be a primary disorder limited to joints or a manifestation of multisystemic disease. Collection and analysis of joint fluid provides valuable information for the diagnosis, prognosis, and treatment of diseases that affect the joint space. The cytologic recognition of the cellular components and infectious agents in synovial fluid categorizes the cell response and differentiates inflammatory and noninflammatory joint disorders. This information is supported by the cell counts, protein content, mucin clot test, bacterial culture, and serologic tests for infectious or immune-mediated disease. These results are integrated with the clinical history, physical examination, radiographic findings, and ancillary test results to arrive at a diagnosis and treatment plan.

ASVCP quality assurance guidelines: control of preanalytical, analytical, and postanalytical factors for urinalysis, cytology, and clinical chemistry in veterinary laboratories.

In December 2009, the American Society for Veterinary Clinical Pathology (ASVCP) Quality Assurance and Laboratory Standards committee published the updated and peer-reviewed ASVCP Quality Assurance Guidelines on the Societys website. These guidelines are intended for use by veterinary diagnostic laboratories and veterinary research laboratories that are not covered by the US Food and Drug Administration Good Laboratory Practice standards (Code of Federal Regulations Title 21, Chapter 58). The guidelines have been divided into 3 reports: (1) general analytical factors for veterinary laboratory performance and comparisons; (2) hematology, hemostasis, and crossmatching; and (3) clinical chemistry, cytology, and urinalysis. This particular report is one of 3 reports and documents recommendations for control of preanalytical, analytical, and postanalytical factors related to urinalysis, cytology, and clinical chemistry in veterinary laboratories and is adapted from sections 1.1 and 2.2 (clinical chemistry), 1.3 and 2.5 (urinalysis), 1.4 and 2.6 (cytology), and 3 (postanalytical factors important in veterinary clinical pathology) of these guidelines. These guidelines are not intended to be all-inclusive; rather, they provide minimal guidelines for quality assurance and quality control for veterinary laboratory testing and a basis for laboratories to assess their current practices, determine areas for improvement, and guide continuing professional development and education efforts.

Acute myeloblastic leukemia with associated BCR-ABL translocation in a dog.

An 8-year-old male neutered Labrador Retriever was referred to the University of Wisconsin Veterinary Medical Teaching Hospital with a presumptive diagnosis of leukemia. Hematologic abnormalities included normal neutrophil count with a left shift, monocytosis, eosinophilia, thrombocytopenia, and circulating immature mononuclear cells. Bone marrow was effaced by immature hematopoietic cells of various morphologic appearances. In addition, large multinucleated cells were observed frequently. Flow cytometric analysis of nucleated cells in blood revealed 34% CD34(+) cells, consistent with acute leukemia. By immunocytochemical analysis of cells in blood and bone marrow, some mononuclear cells expressed CD18, myeloperoxidase, and CD11b, indicating myeloid origin; some, but not all, large multinucleated cells expressed CD117 and CD42b, the latter supporting megakaryocytic lineage. The diagnosis was acute myeloblastic leukemia without maturation (AML-M1). To identify genetic aberrations associated with this malignancy, cells from formalin-fixed paraffin-embedded bone marrow were analyzed cytogenetically by multicolor fluorescence in situ hybridization (FISH). Co-localization of bacterial artificial chromosome (BAC) containing BCR and ABL was evident in 32% of cells. This confirmed the presence of the canine BCR-ABL translocation or Raleigh chromosome. In people, the analogous translocation or Philadelphia chromosome is characteristic of chronic myelogenous leukemia (CML) and is rarely reported in AML. BCR-ABL translocation also has been identified in dogs with CML; however, to our knowledge this is the first report of AML with a BCR-ABL translocation in a domestic animal.

Reference intervals: an essential, expanding, and occasionally equivocal standard

This issue of Veterinary Clinical Pathology includes 2 articles on reference intervals (RI). The authors of these articles draw the salient conclusion that RI require updating because of changes in reference populations and analytical methodology. George et al stress that use of older RI could lead to misinterpretation of clinical data. This is true whenever an RI does not accurately reflect the population for which it is used, and therein lies the dilemma that faces all veterinarians who use RI to make clinical decisions regarding health or the absence thereof: ‘‘Do the RI you use accurately reflect your patient population and current laboratory methods?’’ Accordingly, it is recommended that each laboratory develop RI specific to its methods and patient population. However, developing RI is a costly and time-consuming endeavor, especially for laboratories that provide diagnostic testing for a multitude of species. Add to this the potential differences in RI for various subgroups based on age, breed, gender, and husbandry, and laboratory-specific RI become an overwhelming prospect. The need for separate RI based on physiology and geography is a focus of many articles published in Veterinary Clinical Pathology. In wildlife species, RI are required for monitoring the health of endangered species and the ecosystems in which they live. The breadth of articles published in Veterinary Clinical Pathology, in both captive and free-ranging populations, reflects this growing need. Despite this expanding body of knowledge, the question often remains, ‘‘Can published RI be used in a broader context in diverse clinical situations?’’ The primary problem with using published RI is the frequent lack of detail regarding size and demographics of the reference population, the quality and method of analysis, and the statistical procedures by which RI were determined. Müller et al discuss the difficulty in making a clinical diagnosis using published RI when this crucial information is not provided. The Clinical and Laboratory Standards Institute (CLSI) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recently published updated guidelines for the determination of reference intervals, which were summarized by Geffré at al in a recent issue of Veterinary Clinical Pathology. The basic procedures for determining RI have not changed appreciably over the years. However, in response to concerns over the expense of establishing de novo RI, the updated guidelines include statistical methods for determining RI from smaller sample sizes and specific recommendations for validation of RI transferred from other sources. Examples of these 2 procedures were recently published in this journal. Although the quality of published RI studies has improved, there still is a need for greater consistency in RI determination in the veterinary community. Contributing to this effort, the Quality Assurance and Standards Committee of the American Society for Veterinary Clinical Pathology (ASVCP) is formulating veterinary-specific guidelines for determining RI based on the 2008 CLSI guidelines. With transference and validation now accepted as a viable alternative to establishing de novo RI, emphasis will be on quality of analysis, which is defined by the total error (TE) of a method. Establishing goals for total allowable error (TEA) for analytes measured in animal samples will facilitate the assessment of analytical quality and the ability to use transference. Veterinary clinicians, pathologists, and researchers must work together to expand the body of knowledge concerning RI in a variety of species, under a variety of conditions, and by a variety of methods. Developing useful and practical RI only will be achieved if there is consistency in RI determination, full documentation of study details and method quality, and ongoing publication of results. The ASVCP appreciates the contribution of all our colleagues to this growing and challenging enterprise.

Validation of 2 point-of-care meters for measuring triglycerides in chickens using whole blood and plasma

Disorders of the avian reproductive tract are common, yet monitoring their resolution presents a diagnostic dilemma. Reproductive hormones such as luteinizing hormone or estrogen are the best reflection of reproductive status, but the required sample volumes and lack of reference intervals limit their clinical utility. An alternative analyte is blood triglyceride, the concentration of which rises markedly during sustained estrogen release from the ovary. Portable meters for measuring human blood triglyceride concentration offer the advantage of using minimal sample volumes, but these have not been validated for use in birds. We assessed the precision and accuracy of 2 portable meters for measuring blood triglyceride concentration in pooled whole blood and plasma from chickens (n = 42), and performed method comparison using a reference analyzer and determined total error. Within-run repeatability was fair-to-excellent using whole blood and plasma (range: 2.5–11.5%), and between-run repeatability using plasma was similar (3.1–12.2%). The meters performed well in recovery and dilution studies in which almost all readings fell within the preset requirement of 75–125%. Correlations between each meter, using whole blood and plasma, and the reference analyzer, using plasma only, were high to very high (0.86–0.98). Bias determined by Bland–Altman analysis was similar between whole blood and plasma for each meter, yet markedly different between the meters. The calculated total observed error was consequently within our pre-set total allowable error of 25% for one meter but not the other, indicating the requirement for a meter-specific reference interval.